PF-04418948

Intervention

2 papers9 findings

PubChem

  • 2 independent labs in 1 country
  • Funders: Colorado State University and 2 more
  • 4 of 9 findings with company ties
  • Animals2

Outcomes

6

Cellular senescence

downin mice2

2 studies
  1. PF-04418948 decreases cellular senescence in mice.

    “decreasing both total macrophages (CD68+) and senescent macrophages (CD68+P21+)”

    Animalsin DKO-Hom miceskeletal muscle2 weeks

    Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double-Knockout Mice

    CellsJan 14, 2025

  2. PF-04418948 decreases cellular senescence in mice.

    “decreasing both total macrophages (CD68+) and senescent macrophages (CD68+P21+)”

    Animalsin DKO-Hom miceskeletal muscle2 weeks

    Targeting EP2 receptor improves muscle and bone health in dystrophin-/-/utrophin-/- double knockout mice

    Preprints.orgNov 4, 2024Preprint

More on Cellular senescence

Heterotopic ossification

downin mice2

2 studies
  1. PF-04418948 decreases heterotopic ossification in mice.

    “reduced HO and muscle pathology”

    Animalsin DKO-Hom miceskeletal muscle2 weeks

    Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double-Knockout Mice

    CellsJan 14, 2025

  2. PF-04418948 decreases heterotopic ossification in mice.

    “Treatment of DKO-Hom mice with the EP2 antagonist PF04418948 for 2 weeks, increased body weight, reduced HO”

    Animalsin DKO-Hom mice2 weeks

    Targeting EP2 receptor improves muscle and bone health in dystrophin-/-/utrophin-/- double knockout mice

    Preprints.orgNov 4, 2024Preprint

More on Heterotopic ossification

Body weight

upin mice2

2 studies
  1. PF-04418948 increases body weight in mice.

    “Treatment of DKO-Hom mice with the EP2 antagonist PF04418948 for 2 weeks increased body weight”

    Animalsin DKO-Hom mice2 weeks

    Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double-Knockout Mice

    CellsJan 14, 2025

  2. PF-04418948 increases body weight in mice.

    “Treatment of DKO-Hom mice with the EP2 antagonist PF04418948 for 2 weeks, increased body weight”

    Animalsin DKO-Hom mice2 weeks

    Targeting EP2 receptor improves muscle and bone health in dystrophin-/-/utrophin-/- double knockout mice

    Preprints.orgNov 4, 2024Preprint

Bone volume fraction

upin mice1

1 study
  1. PF-04418948 increases bone volume fraction in mice.

    “PF04418948 also increased bone volume/total volume (BV/TV), the trabecular thickness (Tb.Th) of the tibia trabecular bone, and the cortical bone thickness”

    Animalsin DKO-Hom micebone2 weeks

    Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin-/-/Utrophin-/- Double-Knockout Mice

    CellsJan 14, 2025

More on Bone volume fraction

Bone volume/total volume

upin mice1

1 study
  1. PF-04418948 increases bone volume/total volume in mice.

    “PF04418948 also increased bone volume/total volume (BV/TV), trabecular thickness (Tb.Th) of the tibia trabecular bone and the cortical bone thickness of both the femur and tibia”

    Animalsin DKO-Hom micebone2 weeks

    Targeting EP2 receptor improves muscle and bone health in dystrophin-/-/utrophin-/- double knockout mice

    Preprints.orgNov 4, 2024Preprint

More on Bone volume/total volume

Muscle pathology

downin mice1

1 study
  1. PF-04418948 decreases muscle pathology in mice.

    “Treatment of DKO-Hom mice with the EP2 antagonist PF04418948 for 2 weeks, increased body weight, reduced HO and muscle pathology”

    Animalsin DKO-Hom mice2 weeks

    Targeting EP2 receptor improves muscle and bone health in dystrophin-/-/utrophin-/- double knockout mice

    Preprints.orgNov 4, 2024Preprint

Latest